This website uses cookies to enhance the user experience.
||
TF

Tore Foss1966

Shareholdings
2
6
Norway Business roles
19

Roles

Management

NameRoleTotal operating incomeTotal equityShares
F
FOSS INNOVATIONS AS
Managing Director/CEO
2,214,989
653,980
100 %
directly
G
GARNES GRUPPEN AS
Managing Director/CEO
5,630,387
1,475,025
20 %
indirectly
G
GARNES DATA AS
Managing Director/CEO
59,215,268
6,191,286
19.46 %
indirectly
Q
QWIPS SERVICE SOLUTIONS AS
Managing Director/CEO
4,297,246
3,640,317
19.3 %
indirectly
C
CYBERON SECURITY AS
Managing Director/CEO
8,658,180
947,044
14.7 %
indirectly
C
CLINITECH HJELPESELSKAP AS
Managing Director/CEO
-
-
-
M
MEDTECH NORDIC HOLDING AS
Managing Director/CEO
-
-
-
C
CLINITECH AS
Managing Director/CEO
-
-
-
C
CLINITECH NORGE AS
Managing Director/CEO
-
-
-

Boards

NameRoleTotal operating incomeTotal equityShares
F
FOSS INNOVATIONS AS
Chairman
2,214,989
653,980
100 %
directly
G
GARNES GRUPPEN AS
Board Member
5,630,387
1,475,025
20 %
indirectly
G
GARNES DATA AS
Board Member
59,215,268
6,191,286
19.46 %
indirectly
Q
QWIPS SERVICE SOLUTIONS AS
Board Member
4,297,246
3,640,317
19.3 %
indirectly
C
CYBERON SECURITY AS
Chairman
8,658,180
947,044
14.7 %
indirectly
B
BOOX AS
Board Member
3,409,792
443,840
12.94 %
indirectly
C
CLINITECH HJELPESELSKAP AS
Chairman
-
-
-
M
MEDTECH NORDIC HOLDING AS
Chairman
-
-
-
C
CLINITECH AS
Chairman
-
-
-
C
CLINITECH NORGE AS
Chairman
-
-
-
Last update: Feb 27, 2026

Shares owned by Tore Foss

NameShare classTotal operating incomeTotal equityShare
F
FOSS INNOVATIONS AS
Ordinære aksjer
2,214,989
653,980
100 %
directly
G
GARNES GRUPPEN AS
5,630,387
1,475,025
20 %
indirectly
G
GARNES DATA AS
59,215,268
6,191,286
19.46 %
indirectly
Q
QWIPS SERVICE SOLUTIONS AS
4,297,246
3,640,317
19.3 %
indirectly
C
CYBERON SECURITY AS
8,658,180
947,044
14.7 %
indirectly
B
BOOX AS
3,409,792
443,840
12.94 %
indirectly
A
AVEE AS
2,371,980
-255,199
8 %
indirectly
Ordinære aksjer
0
222,617
4.76 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025